How is the BioNexus Gene Lab Corp today?

The BioNexus Gene Lab Corp today is trading in the green, up by 1.12% at 2.72.

How has BioNexus Gene Lab Corp performed historically?

The BioNexus Gene Lab Corp is currently trading up 1.12% on an intraday basis in the past week the index fell -5.56%. The index has been up 580.00% in the past quarter and rose 353.33% in the past year. You can view this in the overview section.

What is BioNexus Gene Lab Corp Annual Revenue?

BioNexus Gene Lab Corp Annual Revenue fell 2.66%, in the last year to $9.51 M. Its sector's average revenue growth for the last fiscal year was 0.9%.

What is BioNexus Gene Lab Corp Annual Net Profit?

BioNexus Gene Lab Corp Annual Net Profit rose 39.2% in the last year to $1.6 M. Its sector's average net profit growth for the last fiscal year was -14.61%.

What is BioNexus Gene Lab Corp Price to Earning Ratio?

BioNexus Gene Lab Corp Price to Earning Ratio is -3.06, which is negative.

What is BioNexus Gene Lab Corp Stock Price?

BioNexus Gene Lab Corp Stock Price rose 353.33% and outperformed its sector by 335.92% in the past year.

What is BioNexus Gene Lab Corp Quarterly Revenue?

BioNexus Gene Lab Corp Quarterly Revenue rose 11.03% YoY to $2.52 M. Its sector's average revenue growth YoY for the quarter was 2.9%.

What is BioNexus Gene Lab Corp Quarterly Net profit?

BioNexus Gene Lab Corp Quarterly Net profit fell 212.92% YoY to $0.35 M. Its sector's average net profit growth YoY for the quarter was -52.66%.

What is BioNexus Gene Lab Corp Debt to Equity Ratio?

BioNexus Gene Lab Corp Debt to Equity Ratio of 0.03 is less than 1 and healthy. This implies that its assets are financed mainly through equity.

What is BioNexus Gene Lab Corp Return on Equity(ROE)?

BioNexus Gene Lab Corp Return on Equity(ROE) for the last financial year was -17.78%, less than 10%, indicating an inefficient use of shareholder's capital to generate profit.

What is BioNexus Gene Lab Corp Mutual Fund Holding?

BioNexus Gene Lab Corp Mutual Fund Holding increased by 1.19% in the last quarter to 1.32.

What is BioNexus Gene Lab Corp Interest Coverage Ratio?

BioNexus Gene Lab Corp Interest Coverage Ratio is -74.42, lesser than one. This means that it is unable to pay interests with its earnings (EBIT).

What is BioNexus Gene Lab Corp Institutional Holding?

BioNexus Gene Lab Corp Institutional Holding remained the same in the last quarter at 0.99%.

BioNexus Gene Lab Corp XNAS: BGLC

BioNexus Gene Lab Corp Live Share Price Today, Share Analysis and Chart

Name: BioNexus Gene Lab Corp: Is Infosys Ltd. worth buying?
Item: BioNexus Gene Lab Corp
Rating: 2.52483325
Author: Trendlyne DVM scores

about

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. Th...

2.72 0.03 (1.12%)

1195.24% Gain from 52W Low

30,053 XNAS Volume

XNAS 05 May, 2025 5:30 PM (EDT)

Board Meeting

The next board meeting for BioNexus Gene Lab Corp is on 15 May 2025 for the purpose of BioNexus Gene Lab Corp First Quarter Earnings Results for 2025 See details

Not Eligible

Expensive Valuation

25.3 / 100

Technically Bullish

75.7 / 100

No estimates available

BioNexus Gene Lab Corp Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

BioNexus Gene Lab Corp Live Share Price Today, Share Analysis and Chart

BioNexus Gene Lab Corp, through its wholly owned subsidiary, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. Th...

1195.24% Gain from 52W Low

SWOT Analysis

BioNexus Gene Lab Corp Live Price Chart

BioNexus Gene Lab Corp FAQ

How is BioNexus Gene Lab Corp today?

BioNexus Gene Lab Corp today is trading in the green, and is up by 1.12% at 2.72.

How has BioNexus Gene Lab Corp performed historically?

BioNexus Gene Lab Corp is currently trading up 1.12% on an intraday basis. In the past week the stock fell -5.56%. stock has been up 580.00% in the past quarter and rose 353.33% in the past year. You can view this in the overview section.